Rain Oncology Inc. Research and Development in Process
Rain Oncology Inc. reported Research and Development in Process of $5.50 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Notes
us-gaap:ResearchAndDevelopmentInProcess · last filed 2022-03-03
- Rain Oncology Inc. research and development in process for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Rain Oncology Inc. research and development in process for the quarter ending 2020-12-31 was $14.00K.
- Rain Oncology Inc. research and development in process for fiscal 2021 was $5.50M, a 6.44% increase from fiscal 2020.
- Rain Oncology Inc. research and development in process for fiscal 2020 was $5.17M.
| Period end | Research and Development in Process 3 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $5.50M 10-K · filed 2022-03-03 | |
| 2021-09-30 | $5.50M 10-Q · filed 2021-11-10 | ||
| 2020-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $5.17M 10-K · filed 2022-03-03 | |
| 2020-09-30 | $5.15M 10-Q · filed 2021-11-10 |